Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back
- 30 November 1989
- journal article
- clinical trial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (11) , 453-458
- https://doi.org/10.1016/s0165-6147(89)80010-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The eicosanoids and their biochemical mechanisms of actionBiochemical Journal, 1989
- Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.Journal of Clinical Investigation, 1987
- Estimated rate of thromboxane secretion into the circulation of normal humans.Journal of Clinical Investigation, 1986
- Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.Circulation, 1985
- The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.Circulation, 1985
- Arachidonate metabolism in vascular disorders.Journal of Clinical Investigation, 1983
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- EFFECTS OF SALICYLATES ON HUMAN PLATELETSThe Lancet, 1968